Targeting pancreatic cancer-associated fibroblast vulnerabilities in link with their secretory phenotype
Christophe Quémerais(Centre National de la Recherche Scientifique), Corinne Bousquet(Centre National de la Recherche Scientifique), Christine Jean(Centre National de la Recherche Scientifique), Christian Touriol(Centre National de la Recherche Scientifique), Stéphane Pyronnet(Centre National de la Recherche Scientifique), Sonia Zaghdoudi(Centre National de la Recherche Scientifique), Sauyeun Shin(Centre National de la Recherche Scientifique), Nelson Dusetti(Centre National de la Recherche Scientifique), Yvan Martineau(Centre National de la Recherche Scientifique), Rémy Nicolle(Centre National de la Recherche Scientifique)
Cited by 0
Related Papers
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
Autoregulation of pituitary corticotroph SOCS-3 expression: Characterization of the murine SOCS-3 promoter
|Proceedings of the National Academy of Sciences|1999|290
Inter‐ and intra‐tumoural heterogeneity in cancer‐associated fibroblasts of human pancreatic ductal adenocarcinoma
|The Journal of Pathology|2018|284